Start Evaluation
Share your goals, medical history and medications securely.
← EXPLORE YOUR OPTIONSYOUR GOAL / Improve performance
Performance & Recovery
CJC-1295 + Ipamorelin
For people who want to explore their performance, training and recovery goals with a clinician.
Why this program?
CJC-1295 and ipamorelin act through different growth-hormone signaling pathways. The program brings those pathways into one physician-supervised discussion of performance, recovery and body-composition goals.
Intended program goals
Performance · Recovery · Body composition
Clinician Review
A licensed clinician reviews suitability, risks and alternatives.
Prescription & Fulfillment
If appropriate and available, a prescription proceeds through the licensed pharmacy process.
Follow-Up & Refills
Ongoing clinical review guides monitoring and refill decisions.
THE INGREDIENTS / THE RATIONALEGet to know
Get to know
your program.
Tap an ingredient for a two-sentence explanation.
Growth-hormone signaling
CJC-1295
CJC-1295 is a growth-hormone-releasing hormone analogue studied for its effect on growth-hormone signaling. Human research on particular formulations measured hormone levels, not proven performance or recovery benefits from this combination.
Human hormone-response study ↗A different signaling pathway
Ipamorelin
Ipamorelin is a peptide that stimulates growth-hormone release through a different receptor pathway from CJC-1295. That biological rationale explains the pairing under exploration, but does not establish the combination’s clinical benefits.
Preclinical pharmacology ↗Important Treatment Information
Intended goals and biological mechanisms do not establish clinical outcomes for this formulation. Individual response varies; benefits are not guaranteed.
Evidence for this combination is limited. It is not an FDA-approved combination, and performance or recovery benefits are not established for this program.
Treatment requires individual medical evaluation and a prescription where applicable. It depends on clinician judgment, eligibility, and verified pharmacy and state availability. A program selection does not guarantee treatment.
Compounded medications are not FDA-approved; FDA does not review them for safety, effectiveness or quality before marketing. Approval or evidence for one ingredient or branded medicine does not establish the same for this formulation. Outcomes vary and are not guaranteed.
Discuss adverse effects, interactions, pregnancy or reproductive considerations and appropriate alternatives with your clinician. Formulation, route, dosing and monitoring must be confirmed before treatment.
Read the full medical & treatment information ↗BEFORE YOU COMMIT
How payment works.
No payment is taken in this preview.
Working monthly prices are shown. Final charges and inclusions remain unconfirmed.
Evaluation & payment
- Is the evaluation included?
- Not yet confirmed. Must be disclosed before enrollment.
- When am I charged?
- Not yet confirmed. Must be disclosed before enrollment.
- How can I pay?
- Not yet confirmed. Must be disclosed before enrollment.
- What if treatment is not prescribed?
- Not yet confirmed. Must be disclosed before enrollment.
What the price includes
- Is shipping included?
- Not yet confirmed. Must be disclosed before enrollment.
- Are supplies included?
- Not yet confirmed. Must be disclosed before enrollment.
- Are labs included?
- Not yet confirmed. Must be disclosed before enrollment.
- Are there other required fees?
- Not yet confirmed. Must be disclosed before enrollment.
- Are follow-up and refills included?
- Not yet confirmed. Must be disclosed before enrollment.
Billing & cancellation
- How often am I billed?
- Not yet confirmed. Must be disclosed before enrollment.
- Does it renew automatically?
- Not yet confirmed. Must be disclosed before enrollment.
- How do I cancel?
- Not yet confirmed. Must be disclosed before enrollment.
Timing & delivery
- How long does the evaluation take?
- Not yet confirmed. Must be disclosed before enrollment.
- When will treatment arrive?
- Not yet confirmed. Must be disclosed before enrollment.